India’s NPPA Updates Price Caps on 107 Scheduled Drug Formulations

December 26, 2022

India’s National Pharmaceutical Pricing Authority (NPPA) has announced it updated its ceiling price for 107 scheduled formulations, as per the drug (prices control) order, 2013 (NLEM 2022). This includes drugs like acetaminophen, risperidone, heparin, atorvastatin, levofloxacin, and more. The ceiling price update will cap the maximum price of drugs to retailers.

According to Susmita Roy, “Scheduled formulation means any formuilation, included in the First Schedule whether referred to byt generic versions or brand name (mainly products covered under National List of Essential Medicines are Scheduled Formulation). In other words, all medicines that are covered in National List of Essential Medicine, which are notified in Schedule 1, by the Govt. are scheduled formulation”

To read more, click here.

(Source: Medical Dialogues, December 24th, 2022)

Share This Story!